Jean Noël Nyemb | Medicinal Chemistry | Editorial Board Member

Published on by Top Pharmaceutical

Assist. Prof. Dr. Jean Noël Nyemb | Medicinal Chemistry | Editorial Board Member

The University of Maroua | Cameroon

Assist. Prof. Dr. Jean Noël Nyemb is a distinguished Cameroonian scholar in Organic Chemistry, widely recognized for his contributions to natural products chemistry, medicinal chemistry, and applied chemical sciences. He serves as a Senior Lecturer in the Department of Refining and Petrochemistry at the National Advanced School of Mines and Petroleum Industries, University of Maroua, where he plays a leading role in teaching, research, postgraduate supervision, and curriculum development. Over the course of his academic journey, he has held several positions across respected higher education institutions, including the University of Maroua, the University of Ngaoundere, and the Higher Institute of Science and Technology of Yaounde. His progressive career includes roles as Instructor, Lecturer, Part-time Lecturer, Research Fellow, and ultimately Senior Lecturer, reflecting a consistent record of academic excellence, professional growth, and dedication to scientific advancement.Dr. Nyemb earned his Ph.D. in Organic Chemistry with the highest distinction, specializing in Natural Products Chemistry, following a strong academic foundation that includes graduate and undergraduate degrees in Organic and Applied Chemistry. His scientific expertise covers the isolation, characterization, and structural elucidation of secondary metabolites, the synthesis and semi-synthesis of biologically active compounds, and the evaluation of their pharmacological potential, including antimicrobial, antioxidant, enzyme-inhibitory, and chemotaxonomic relevance. His research further integrates molecular docking, computational drug design, pharmacokinetics, toxicology, enzymology, and biochemistry, illustrating his multidisciplinary approach to discovering bioactive molecules with therapeutic value.With more than forty publications, an impressive cumulative impact factor, and numerous articles as principal or co-author, Dr. Nyemb has established himself as a productive scientist in his field. His works span areas such as phytochemical profiling, medicinal plant research, natural compound synthesis, and biological activity evaluation. His publications are well-cited globally, and his h-index reflects strong scholarly influence. Dr. Nyemb is also actively involved in ongoing research projects focusing on bioactive compounds from Vernonia species and members of the Zingiberaceae family, highlighting his interest in medicinal plants and ethnopharmacological resources.

Citation Metrics (Google Scholar)

500400

300

200

100

0

Citations
487

h-index
11

i10-index
13

Citations
h-index
i10-index


View Google Scholar Profile

Featured Publications

Galal Elgemeie | Medicinal Chemistry | Best Researcher Award

Published on by Top Pharmaceutical

Prof. Dr. Galal Elgemeie | Medicinal Chemistry | Best Researcher Award

Helwan University | Egypt

Prof. Elgemeie stands as a distinguished figure in the field of organic and medicinal chemistry, with a research career deeply rooted in the development and mechanistic understanding of organic reactions and their applications in synthesizing antimetabolic agents. His scholarly pursuits bridge fundamental chemistry with biomedical innovation, particularly in the discovery of novel therapeutic compounds aimed at combating cancer and viral diseases. Through his extensive academic contributions, he has established a legacy of excellence that continues to inspire scientists and researchers globally.An internationally recognized scientist, Prof. Elgemeie was elected as a member of the Scientific Board of the International Basic Sciences Programme (IBSP) under UNESCO in Paris, France, reflecting his global influence and leadership in advancing the chemical sciences. His postdoctoral experiences across Germany, the United States, and England—supported by prestigious foundations such as the Alexander von Humboldt Foundation, the Fulbright Program, and the British Council—shaped his multidisciplinary expertise and broadened his research collaborations across continents.Prof. Elgemeie’s innovative research has led to numerous impactful projects, including the design and synthesis of novel epigenetic small molecules and antimetabolites in collaboration with the Institute of Medicinal Chemistry, Düsseldorf University. His pioneering work in developing sofosbuvir analogues for treating hepatitis C virus (HCV) and hepatocellular carcinoma among Egyptian patients demonstrates his commitment to translating scientific discovery into therapeutic applications with real-world benefits.His publication record is exceptional, with over 270 papers indexed in international databases such as Scopus, and his scientific influence is further underscored by a significant citation index. He has authored influential scientific books with leading publishers like Elsevier, offering comprehensive insights into cancer metabolism and heterocyclic chemistry. Prof. Elgemeie also holds several patents in process, reflecting his drive to innovate beyond academia and contribute to industry-based advancements in medicinal chemistry.Serving as an editorial board member for prominent journals including Current Microwave Chemistry, he continues to guide the global scientific dialogue in his field. His collaborations span several institutions worldwide, reinforcing his reputation as a bridge between Egyptian and international research communities.Beyond research, Prof. Elgemeie has played a vital role in educational reform and academic development across Egypt and the Arab region. He has supervised multiple cooperative projects with the European Community under the TEMPUS programme, contributing to the restructuring of higher education and aligning it with international standards. These initiatives have significantly advanced institutional capacity and innovation within Mediterranean and Arab universities.

Profile: Orcid

Featured Publications

Azzam, R. A., Seif, M. M., El-Demellawy, M. A., & Elgemeie, G. H. (2025). Novel 2-substituted benzothiazole derivatives: Synthesis, in vitro and in silico evaluations as potential anticancer agents. RSC Advances.

Elgemeie, G. H., Fathy, N. M., & Shaarawi, S. I. (2024). Naphthyl cyanoketene N, S-acetals in glycoside synthesis: A new preparative route to a new class of N-naphthylcyanoacrylamide thioglycosides and their conversions to naphthyl–pyrazole hybrids. Nucleosides, Nucleotides & Nucleic Acids.

Abu-Zaied, M. A., Nawwar, G. A., & Elgemeie, G. H. (2024). Novel synthesis of a new class of substituted S-glycosylisothiourea derivatives and their conversion to 5-amino-1,2,4-triazoles. Synthetic Communications.

Metwally, N. H., Elgemeie, G. H., & Fahmy, F. G. (2023). Synthesis and biological evaluation of benzothiazolyl-pyridine hybrids as new antiviral agents against H5N1 bird flu and SARS-CoV-2 viruses. ACS Omega.

Abdallah, A. E. M., Abdel-Latif, S. A., & Elgemeie, G. H. (2023). Novel fluorescent benzothiazolyl-coumarin hybrids as anti-SARS-COVID-2 agents supported by molecular docking studies: Design, synthesis, X-ray crystal structures, DFT, and TD-DFT/PCM calculations. ACS Omega.

Ahmed, E. A., Elgemeie, G. H., & Azzam, R. A. (2023). Synthesis of new sulfapyrimidine and pyrazolo[1,5-a]pyrimidine derivatives. Synthetic Communications.

Khedr, M. A., Zaghary, W. A., Elsherif, G. E., Azzam, R. A., & Elgemeie, G. H. (2023). Purine analogs: Synthesis, evaluation and molecular dynamics of pyrazolopyrimidines-based benzothiazole as anticancer and antimicrobial CDK inhibitors. Nucleosides, Nucleotides & Nucleic Acids.